Back to Market返回行情

ATON AlphaTON Capital Corp.

USFinancial Services
$0.2320-7.13%ClosedMarket Cap: $528,567

As of 2026-07-08 15:59

Why ATON matters now

AlphaTON Capital Corp. (ATON) is a US stock in Financial Services. The latest InvestLog snapshot shows $0.23 with -7.13% on the session and $528.6K in market capitalization; recent performance reads 1-month -30.25% and YTD -57.92%.

The latest financial table shown here is Q2 2026, with revenue of $0.00, net income of $-10.4M, and EPS of $-4.13. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -62.3%.

The latest indexable market news headline is "CryptoBell.Live Launches National Broadcast Platform across 60 million US households to Bring AI, Blockchain & Crypto Mainstream" from GlobeNewsWire.

Additional event context on this page matters because analyst consensus is Buy with a median target of $4.88; recent insider activity includes Kaiser Brittany filing . These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

PEG

P/B

0.07

P/S

0.00

EV/EBITDA

-0.30

DCF Value

$1.08

FCF Yield

-62.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-925.1%

ROA

-64.4%

ROIC

-116.3%

Financials

PeriodRevenueNet IncomeEPS
Q2 2026$0.00$-10.4M$-4.13
Q1 2026$0.00$-5.6M$-2.57
Q4 2025$0.00$-1.9M$-0.17
FY 2025$0.00$-6.8M$-5.72

Analyst Ratings

Consensus

Buy

Target (Consensus)

$4.88

Target (Median)

$4.88

Target Range

$4.50 - $5.25

Strong Buy: 0Buy: 1Hold: 0Sell: 0Strong Sell: 0

Trading Activity

Insider Trades

Kaiser Brittanydirector, officer: Chief Executive Officer
Sell2026-04-17
Terpin Michaeldirector:
Sell2026-04-09
Villani Fiorenzodirector, officer: Chief Investment Officer
Sell2026-04-07
Levitt Wesley Allenofficer
Sell2026-03-18

Company Info

Sector

Financial Services

Industry

Asset Management

Country

US

Exchange

Beta

0.49

AlphaTON Capital Corp. has undergone a strategic transformation, rebranding from its previous identity as Portage Biotech Inc. While formerly engaged as a clinical-stage immuno-oncology firm, the company is now pivoting its operations towards a digital asset treasury model. This new focus primarily involves the acquisition and staking of Toncoin (TON). AlphaTON's ambition is to make significant investments in TON tokens, with the goal of building a long-term Toncoin treasury valued at approximately US$100 million.